Published in Cardiovascular Business Week, January 9th, 2007
Pletaal has been solely distributed by Otsuka Pharmaceutical in Japan since April 1988.
Under the agreement, Chugai will start co-promotion activities for Pletaal in the hemodialysis market in March 2007.
Pletaal is an antiplatelet agent with a platelet aggregation inhibitory action and a vasodilating action developed by Otsuka Pharmaceutical. Indicated for improvement of ischemic symptoms including ulcer,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.